Anzeige
Mehr »
Donnerstag, 25.12.2025 - Börsentäglich über 12.000 News
Prof. Dr. Dr. Andreas Pfützner: Geniale Lösung für Diabetiker!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0M103 | ISIN: BE0003874915 | Ticker-Symbol: 4A5
Tradegate
23.12.25 | 19:24
21,300 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
BEL Mid
AMX
1-Jahres-Chart
FAGRON NV Chart 1 Jahr
5-Tage-Chart
FAGRON NV 5-Tage-Chart
RealtimeGeldBriefZeit
21,25021,30023.12.
21,25021,35023.12.

Aktuelle News zur FAGRON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrFagron: Zwei Akquisitionen stärken Geschäft in Asien und Brasilien1
FrFagron expands with two acquisitions in APAC and Brazil1
FrFagron NV: Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone150Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 19 December 2025 - 7:00 AM CET Fagron accelerates global expansion with two strategic acquisitions and a key...
► Artikel lesen
FAGRON Aktie jetzt für 0€ handeln
24.11.Fagron Announces Acquisitions Of Amara And Magilab8
24.11.Fagron NV: Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business189Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 - 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary...
► Artikel lesen
14.11.Fagron NV: Fagron completes share buy-back program1
07.11.Fagron NV: Fagron's share buy-back program: Weekly update1
31.10.Fagron NV: Fagron's share buy-back program: Weekly update2
24.10.Fagron NV: Fagron's share buy-back program: Weekly update1
17.10.Fagron NV: Fagron's share buy-back program: Weekly update2
09.10.Fagron NV Q3 Revenue Up 6,4%; Backs FY25 Revenue Outlook; Announces Share Buyback1
09.10.Fagron NV: Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook199Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 9 October 2025 - 7:00 AM CET Fagron reports solid third quarter performance with 6.4% revenue growth and confirms...
► Artikel lesen
06.10.Fagron NV: Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions232Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 October 2025 - 7:00 AM CET Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions...
► Artikel lesen
29.09.Fagron NV: Fagron increases share capital through exercise subscription rights1
25.09.Fagron NV: Fagron announces the acquisition of UCP in North America and FDA inspection update296Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 25 September 2025 - 7:00 AM CET Fagron announces the acquisition of UCP in North America and FDA inspection...
► Artikel lesen
05.09.Fagron NV: Disclosure of notification received from Mawer14
31.07.Fagron NV: Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025548Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 31 July 2025 - 7:00 AM CET Fagron delivers strong performance with 11% topline growth and 12% increase in...
► Artikel lesen
18.07.Fagron NV: Disclosure of notification received from Alychlo8
06.06.Fagron NV: Fagron increases share capital through exercise subscription rights599Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 June 2025 - 7PM CET Fagron increases share capital through exercise subscription rights Fagron announces that as a result of...
► Artikel lesen
10.04.Fagron NV: Record first-quarter revenue of €239 million, reflecting 14% topline growth796Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2025 - 7:00 AM CET Record first-quarter revenue of €239 million, reflecting 14% topline growth Fagron...
► Artikel lesen
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1